Clinical Trial Update: Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating hydroxychloroquine in children with genetic interstitial lung diseases caused by surfactant dysfunction, and the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Surfactant Dysfunction

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Interstitial Lung Disease, Surfactant Dysfunction | EARLY_Phase 1 | Status: RECRUITING